Cleared Traditional

K832559 - OCUCARE FREEDOM PACK

K832559 is an FDA 510(k) clearance for OCUCARE FREEDOM PACK, manufactured by Ocular Innovations, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 59-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1983
Decision
59d
Days
Class 2
Risk

K832559 is an FDA 510(k) clearance for the OCUCARE FREEDOM PACK. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Ocular Innovations, Inc. (Mchenry, US). The FDA issued a Cleared decision on September 29, 1983 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K832559

510(k) Number K832559 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 01, 1983
Decision Date September 29, 1983
Days to Decision 59 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 110d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 316
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K832559.
VXTRA OCUTOME KIT
K832980 · Vxtra Corp. · Oct 1983
SIAS IRRIGATION/ASPIRATION SYSTEM
K832413 · Clark Pool & Assoc. · Oct 1983
EPA AUTOMATED INFUSION POLE
K832997 · Miami Eye Technology, Inc. · Oct 1983
ENVISION G21 I/A ENPAK
K832423 · Envision, Inc. · Sep 1983
ENVISION G31 P.E. PAK
K832424 · Envision, Inc. · Sep 1983
UNIVERSAL PACK
K831701 · Atlantic Optical Systems, Inc. · Jul 1983